SS 29 - Lung 3: NSCLC Early Stage and SBRT

Presentations

• 05:00pm - 06:00pm PT

  Lung 3: NSCLC Early Stage and SBRT

  Speaker: Simon Cheng, MD, PhD - Columbia University Irving Medical Center, New York
• 05:00pm - 06:00pm PT

  Lung 3: NSCLC Early Stage and SBRT

  Speaker: Jason Ye, MD - University of Southern California USC Norris Cancer Hospital, Los Angeles
• 05:00pm - 05:10pm PT

  Ten-Year Outcomes of the Revised STARS Trial Comparing Radiation and Surgery for Early-Stage Non-Small Cell Lung Cancer

  Speaker: Troy Kleber, MD, MS - MD Anderson Cancer Center, Houston
• 05:10pm - 05:20pm PT

  Clinical and Genomic Predictors of Local Failure in NSCLC Patients Treated with Lung SBRT

  Speaker: Roshal Patel, MD - Memorial Sloan Kettering Cancer Center, New York
• 05:20pm - 05:30pm PT

  Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial

  Speaker: Alexa Dang, MD - BC Cancer Agency Vancouver, Vancouver
• 05:30pm - 05:40pm PT

  Outcomes of SABR or Surgery for Early-Stage Lung Cancer in Patients with Interstitial Lung Disease (ILD)

  Speaker: Mathijs Tomassen, MD - Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam
• 05:40pm - 05:50pm PT

  A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer

  Speaker: Mark Farrugia, MD, PhD - Roswell Park Cancer Institute, Buffalo
• 05:50pm - 06:00pm PT

  Discussant

  Speaker: Joe Chang, MD, PhD, MS, FASTRO - MD Anderson Cancer Center, Houston